Firoz A. Jaipuri

1.0k total citations
17 papers, 785 citations indexed

About

Firoz A. Jaipuri is a scholar working on Molecular Biology, Organic Chemistry and Biological Psychiatry. According to data from OpenAlex, Firoz A. Jaipuri has authored 17 papers receiving a total of 785 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 10 papers in Organic Chemistry and 4 papers in Biological Psychiatry. Recurrent topics in Firoz A. Jaipuri's work include Glycosylation and Glycoproteins Research (6 papers), Carbohydrate Chemistry and Synthesis (6 papers) and Tryptophan and brain disorders (4 papers). Firoz A. Jaipuri is often cited by papers focused on Glycosylation and Glycoproteins Research (6 papers), Carbohydrate Chemistry and Synthesis (6 papers) and Tryptophan and brain disorders (4 papers). Firoz A. Jaipuri collaborates with scholars based in United States. Firoz A. Jaipuri's co-authors include Nicola L. B. Pohl, Kwang‐Seuk Ko, James Truslow Adams, Mario R. Mautino, Sanjeev Kumar, Jesse P. Waldo, Jared T. Shaw, Sreeman Mamidyala, Nicholas N. Vahanian and Charles J. Link and has published in prestigious journals such as Journal of the American Chemical Society, Angewandte Chemie International Edition and Biochemistry.

In The Last Decade

Firoz A. Jaipuri

17 papers receiving 778 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Firoz A. Jaipuri United States 15 505 350 135 100 70 17 785
Shigehiro Asano Japan 13 348 0.7× 343 1.0× 93 0.7× 161 1.6× 12 0.2× 24 694
Scott Lew United States 15 676 1.3× 101 0.3× 56 0.4× 24 0.2× 57 0.8× 19 827
Lewis Gazzard United States 11 264 0.5× 181 0.5× 27 0.2× 43 0.4× 25 0.4× 14 495
Duncan S. Holmes United Kingdom 16 426 0.8× 339 1.0× 38 0.3× 16 0.2× 44 0.6× 39 692
Willy Kinzy Germany 17 1.2k 2.3× 1.2k 3.3× 15 0.1× 94 0.9× 60 0.9× 27 1.7k
Danish Idrees India 14 426 0.8× 207 0.6× 14 0.1× 22 0.2× 61 0.9× 21 754
Paul Beswick United Kingdom 20 443 0.9× 471 1.3× 32 0.2× 48 0.5× 4 0.1× 38 1.0k
Eric Kitas Switzerland 23 984 1.9× 241 0.7× 8 0.1× 52 0.5× 53 0.8× 33 1.2k
Mark Furber United Kingdom 22 435 0.9× 648 1.9× 23 0.2× 6 0.1× 29 0.4× 55 1.2k
Ka Yang United States 18 788 1.6× 234 0.7× 11 0.1× 9 0.1× 28 0.4× 38 1.2k

Countries citing papers authored by Firoz A. Jaipuri

Since Specialization
Citations

This map shows the geographic impact of Firoz A. Jaipuri's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Firoz A. Jaipuri with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Firoz A. Jaipuri more than expected).

Fields of papers citing papers by Firoz A. Jaipuri

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Firoz A. Jaipuri. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Firoz A. Jaipuri. The network helps show where Firoz A. Jaipuri may publish in the future.

Co-authorship network of co-authors of Firoz A. Jaipuri

This figure shows the co-authorship network connecting the top 25 collaborators of Firoz A. Jaipuri. A scholar is included among the top collaborators of Firoz A. Jaipuri based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Firoz A. Jaipuri. Firoz A. Jaipuri is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Muñoz, Diana M., Marya Liimatta, Firoz A. Jaipuri, et al.. (2023). Abstract 6093: IDE161, a potential first-in-class clinical candidate PARG inhibitor, selectively targets homologous-recombination-deficient and PARP inhibitor resistant breast and ovarian tumors. Cancer Research. 83(7_Supplement). 6093–6093. 9 indexed citations
2.
Kumar, Sanjeev, Firoz A. Jaipuri, Jesse P. Waldo, et al.. (2020). Discovery of indoximod prodrugs and characterization of clinical candidate NLG802. European Journal of Medicinal Chemistry. 198. 112373–112373. 33 indexed citations
3.
Kumar, Sanjeev, Jesse P. Waldo, Firoz A. Jaipuri, et al.. (2019). Discovery of Clinical Candidate (1R,4r)-4-((R)-2-((S)-6-Fluoro-5H-imidazo[5,1-a]isoindol-5-yl)-1-hydroxyethyl)cyclohexan-1-ol (Navoximod), a Potent and Selective Inhibitor of Indoleamine 2,3-Dioxygenase 1. Journal of Medicinal Chemistry. 62(14). 6705–6733. 63 indexed citations
4.
Mautino, Mario R., Sanjeev Kumar, Hong Zhuang, et al.. (2017). Abstract 4076: A novel prodrug of indoximod with enhanced pharmacokinetic properties. Cancer Research. 77(13_Supplement). 4076–4076. 14 indexed citations
5.
Mautino, Mario R., Richard Metz, Firoz A. Jaipuri, et al.. (2014). Abstract 1633: Novel specific- and dual- tryptophan-2,3-dioxygenase (TDO) and indoleamine-2,3-dioxygenase (IDO) inhibitors for tumor immunotherapy. Cancer Research. 74(19_Supplement). 1633–1633. 5 indexed citations
6.
Mautino, Mario R., Firoz A. Jaipuri, Jesse P. Waldo, et al.. (2013). Abstract 491: NLG919, a novel indoleamine-2,3-dioxygenase (IDO)-pathway inhibitor drug candidate for cancer therapy.. Cancer Research. 73(8_Supplement). 491–491. 70 indexed citations
7.
Maso, Michael J. Di, et al.. (2012). Synthesis of 6,6′-Binaphthopyran-2-one Natural Products: Pigmentosin A, Talaroderxines A and B. Organic Letters. 14(17). 4338–4341. 18 indexed citations
8.
Jaipuri, Firoz A. & Nicola L. B. Pohl. (2008). Toward solution-phase automated iterative synthesis: fluorous-tag assisted solution-phase synthesis of linear and branched mannose oligomers. Organic & Biomolecular Chemistry. 6(15). 2686–2686. 103 indexed citations
9.
Jaipuri, Firoz A., et al.. (2008). Synthesis and Quantitative Evaluation of GlyceroDmanno ‐heptose Binding to Concanavalin A by Fluorous‐Tag Assistance. Angewandte Chemie International Edition. 47(9). 1707–1710. 80 indexed citations
10.
Jaipuri, Firoz A., et al.. (2008). Synthesis and Quantitative Evaluation of GlyceroDmanno‐heptose Binding to Concanavalin A by Fluorous‐Tag Assistance. Angewandte Chemie. 120(9). 1731–1734. 19 indexed citations
11.
Nieland, Thomas J.F., Jared T. Shaw, Firoz A. Jaipuri, et al.. (2007). Influence of HDL-cholesterol-elevating drugs on the in vitro activity of the HDL receptor SR-BI. Journal of Lipid Research. 48(8). 1832–1845. 19 indexed citations
12.
Nieland, Thomas J.F., Jared T. Shaw, Firoz A. Jaipuri, et al.. (2007). Identification of the Molecular Target of Small Molecule Inhibitors of HDL Receptor SR-BI Activity,,. Biochemistry. 47(1). 460–472. 39 indexed citations
13.
Mamidyala, Sreeman, et al.. (2006). Noncovalent fluorous interactions for the synthesis of carbohydrate microarrays. Journal of Fluorine Chemistry. 127(4-5). 571–579. 55 indexed citations
14.
Ko, Kwang‐Seuk, Firoz A. Jaipuri, & Nicola L. B. Pohl. (2005). Fluorous-Based Carbohydrate Microarrays. Journal of the American Chemical Society. 127(38). 13162–13163. 191 indexed citations
15.
Jaipuri, Firoz A., et al.. (2004). Microwave-assisted cleavage of Weinreb amide for carboxylate protection in the synthesis of a ( R )-3-hydroxyalkanoic acid. Tetrahedron Letters. 45(21). 4149–4152. 20 indexed citations
16.
Rahman, Md Mizanur, Firoz A. Jaipuri, & Nicola L. B. Pohl. (2004). One-Step Synthesis of Labeled Sugar Nucleotides for Protein O-GlcNAc Modification Studies by Chemical Function Analysis of an Archaeal Protein. Journal of the American Chemical Society. 127(3). 836–837. 22 indexed citations
17.
Jaipuri, Firoz A., et al.. (2003). Protic acid-catalyzed polymerization of β-lactones for the synthesis of chiral polyesters. Tetrahedron Asymmetry. 14(20). 3249–3252. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026